CompaniesByCap
RNAC
Cartesian Therapeutics Inc. (RNAC)
NASDAQ · Healthcare

Cartesian Therapeutics Inc. PE Ratio 2016–2026

Current and historical P/E ratio for Cartesian Therapeutics Inc. (RNAC), calculated by dividing the latest closing price by the trailing twelve-month earnings per share (EPS). As of it is —.
From: 06/30/2016To: 03/31/2026
Stock Price
TTM Net EPS
PE Ratio

Cartesian Therapeutics Inc. PE Ratio — FAQ

Cartesian Therapeutics Inc. (RNAC) pe ratio over the last 12 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see RNAC's pe ratio history?

The chart and table above show Cartesian Therapeutics Inc.'s pe ratio by year and by quarter, including the growth rate.